Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
01/2013
01/02/2013CN102858748A Therapeutic agent and preventative agent for Alzheimer's disease
01/02/2013CN102858735A N-carbomethoxy-n-methoxy-(2-chloromethyl)-anilines, their preparation and their use as precursors for preparing 2-(pyrazol-3'-yloxymethylene)-anilides
01/02/2013CN102850274A Method for synthesizing chiral spiro-pyrazolone
01/02/2013CN101765589B Fungicide N-cycloalkyl-N-bicyclic-carboxamide derivatives
01/02/2013CN101084195B 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
01/01/2013US8344157 Process for preparing 1,3-disubstituted pyrazolecarboxylic esters
01/01/2013US8344156 Method for producing fluorine-containing acylacetic acid derivative, method for producing fluorine-containing pyrazolecarboxylic acid ester derivative, and method for producing fluorine-containing pyrazolecarboxylic acid derivative
01/01/2013US8344015 2-alkyl-cycloalk(en)yl-carboxamides
01/01/2013US8343976 Compounds, compositions and methods comprising pyrazole derivatives
01/01/2013US8343970 PDE10 inhibitors and related compositions and methods
01/01/2013US8343913 Hsp90, buffering and drug resistance
12/2012
12/27/2012WO2012176763A1 Novel indazole derivative
12/27/2012WO2012176717A1 Method for producing pyrazole compound
12/27/2012WO2012175654A1 Tetraline sulfonamide derivatives for use in the treatment of proliferative disorders
12/27/2012WO2012175511A1 Method for producing pyrazolylcarboxanilides
12/27/2012WO2012137152A3 Method for preparing formamide compounds
12/27/2012WO2011115725A3 Indazole compounds as kinase activity modulators for the treatment of cancer and related disorders
12/27/2012US20120329847 Pyrazole microbiocides
12/26/2012EP2536692A1 Pyrazole microbiocides
12/26/2012CN102844306A Process for preparation of pyrazole carboxylic acid amide
12/26/2012CN102838546A Pyrazole derivatives as modulators of 5-ht2a serotonin receptor useful for treatment of disorders related thereto
12/26/2012CN102838545A Crystalline form IV of celecoxib, preparation method and purpose thereof
12/26/2012CN102838544A Crystalline form II of celecoxib, preparation method and purpose thereof
12/26/2012CN102838543A Crystalline form III of celecoxib, preparation method and purpose thereof
12/26/2012CN102838542A Crystalline form I of celecoxib, preparation method and purpose thereof
12/26/2012CN101312952B 四氢-环戊二烯并吡唑大麻素调节剂 Tetrahydro - cyclopenta pyrazole cannabinoid modulators
12/26/2012CN101062916B Three-substituted 1H-pyrromonazole compound, preparation method, medicament composition and pharmacy use thereof
12/25/2012US8338611 Opioid receptor antagonists
12/25/2012US8338434 Inhibitors of Akt activity
12/25/2012US8338418 Dual-acting antihypertensive agents
12/20/2012WO2012174362A1 Pyrazole derivatives as cannabinoid receptor 1 antagonists
12/20/2012WO2012173849A1 Pyrazole derivatives useful as aldosterone synthase inhibitors
12/20/2012WO2012172473A1 Cysteine protease inhibitors
12/20/2012US20120323017 Dinitropyrazole derivatives, their preparation, and energetic compositions comprising them
12/20/2012US20120322842 Heterocycyl-substituted-alkylaminophenyl derivatives, their preparation and use as medicaments
12/20/2012US20120322841 Aldosterone Synthase Inhibitor
12/20/2012CA2836804A1 Pyrazole derivatives useful as aldosterone synthase inhibitors
12/19/2012EP2535334A1 Crystalline modifications of penflufen
12/19/2012EP2535327A1 Insecticidal 3-acylaminobenzanilides
12/19/2012CN102834383A Cysteine protease inhibitors
12/19/2012CN102834382A Pyrazole derivatives as modulators of calcium release-activated calcium channel
12/19/2012CN102827082A Thienopyrazole derivative having PDE7 inhibitory activity
12/19/2012CN102827081A Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor
12/19/2012CN101421218B Cycloalkyl-phenylsubstituierte cyclische ketoenole
12/18/2012US8334390 Fungicide N-cycloalkyl-N-bicyclic-carboxamide derivatives
12/18/2012US8334316 Substituted organosulfur compounds and methods of using thereof
12/18/2012US8334315 Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
12/18/2012CA2671776C Gal3 receptor antagonists for the treatment of depression
12/18/2012CA2517517C P38 inhibitors and methods of use thereof
12/13/2012WO2012168852A1 Cysteine protease inhibitors
12/13/2012WO2012138254A3 Pharmacologically active 4,4'-biphenylamide derivatives and drugs based thereon
12/13/2012WO2012007938A8 Fipronil production process
12/13/2012US20120316193 Proteostasis regulators
12/13/2012US20120316169 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them
12/13/2012US20120316150 Amide compounds useful in therapy
12/12/2012EP2531490A1 Cyclohexyl amide derivatives as crf receptor antagonists
12/12/2012EP2531177A1 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates
12/12/2012CN1938278B Process for producing 5-hydroxy-4-thiomethylpyrazole compound
12/12/2012CN102822148A Therapeutic agent or prophylactic agent for fibromyalgia
12/12/2012CN102816118A Catalytic synthesis method of mefenpyr-diethyl
12/12/2012CN102816081A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
12/12/2012CN101955460B Method for preparing 5-amino-3-cyano-1-(2,6-dichloro-4-trifluoromethylphenyl)-4-trifluoromethylsulfinyl pyrazol
12/12/2012CN101331119B Benzoylpyrazole compounds and herbicides containing them
12/11/2012US8329899 Pyrazole compounds that modulate HSP90 activity
12/11/2012US8329880 Process for the preparation of naphthalen-2-yl-pyrazol-3-one intermediates useful in the synthesis of sigma receptor inhibitors
12/11/2012CA2576144C Sigma receptor inhibitors
12/11/2012CA2563461C Pyrazole phenyl derivatives as ppar activators
12/06/2012WO2012166387A1 Neprilysin inhibitors
12/06/2012WO2012165547A1 Method for manufacturing pyrazole derivative
12/06/2012WO2012165314A1 Amide compound
12/06/2012WO2012164571A1 Process for synthesis of fipronil
12/06/2012WO2012163905A1 Method for preparing a fluorinated organic compound
12/06/2012WO2012163896A1 Method for the preparation of a fluoro-methylpyrazole compound in carboxylic acid or derivative form
12/06/2012US20120309806 Process for the Sulfinylation of a Pyrazole Derivative
12/06/2012US20120309673 Cysteine protease inhibitors
12/06/2012US20120308588 Neprilysin inhibitors
12/06/2012US20120308587 Neprilysin inhibitors
12/06/2012CA2835216A1 Neprilysin inhibitors
12/05/2012EP2529740A1 Methods of preparing 4-Phenyl-6(2,2,2-Trifluoro-1-Phenylethoxy) Pyrimidine-based compounds.
12/05/2012EP2528902A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
12/05/2012EP2528901A1 Pyrazole compounds as crth2 antagonists
12/05/2012EP2528900A1 Synthesis of substituted pyrazoline carboxamidine derivatives
12/05/2012CN102812009A Method for the synthesis of 5-amino, 1-phenyl, 3-cyano, 4-trifluoromethyl sulfinyl pyrazole
12/05/2012CN102812008A Therapeutic agent or preventive agent for urine collection disorder
12/05/2012CN102807531A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
12/04/2012US8324420 Process for producing acrylonitrile compound
12/04/2012US8324265 Heterocyclic compounds having type I 11β hydroxysteroid dehydrogenase inhibitory activity
12/04/2012US8324264 Inhibitors of bacterial biofilms and related methods
12/04/2012US8324263 Microbiocidally active carboxamides
12/04/2012US8324262 Tricyclic necrostatin compounds
12/04/2012US8324186 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of CCR2
12/04/2012CA2590204C Amide compounds and thrombopoietin receptor activators
12/04/2012CA2543052C Hexyl carboxanilides and their use for controlling undesirable micro-organisms
11/2012
11/29/2012WO2012160447A1 3, 5 -diphenyl- substituted pyrazolines for the treatment of cancer, proliferative, inflammatory or autoimmune diseases
11/29/2012WO2012160218A1 Family of aryl, heteroaryl, o-aryl and o-heteroaryl carbasugars
11/29/2012US20120302609 Pyrazolines for the Modulation of PKM2
11/29/2012US20120302597 Novel p2x7r antagonists and their use
11/29/2012CA2835755A1 Family of aryl, heteroaryl, o-aryl and o-heteroaryl carbasugars
11/28/2012EP2527329A1 Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
11/28/2012EP2527315A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 256